Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Language
Publication year range
1.
An Acad Bras Cienc ; 95(2): e20200455, 2023.
Article in English | MEDLINE | ID: mdl-37018833

ABSTRACT

Many of the drugs used to fight cancer cells induce various damage causing hepatotoxic effects which are characterized by tissue changes. The aim of the study is to know the possible effects of salazinic acid on livers of mice exposed to Sacoma-180. The tumor was grown in the animals in ascitic form and inoculated subcutaneously in the axillary region of the mouse developing the solid tumor. Treatment with salazinic acid (25 and 50 mg/kg) and 5-Fluorouracil (20 mg/kg) started 24-hours after inoculation and was performed for 7 days. To verify these effects, the qualitative method of histological criteria investigated in liver tissue was used. It was observed that all treated groups showed an increase of pyknotic nuclei in relation to the negative control. There was an increase in steatosis in all groups compared to the negative control but there was a decrease in the groups treated with salazinic acid in the 5-Fluorouracil. There was no necrosis in the salazinic acid treated groups. However, this effect was seen in 20% of the positive control group. Therefore, it can be concluded that salazinic acid did not show hepatoprotective action on mice but demonstrated a decrease in steatosis and absence of tissue necrosis.


Subject(s)
Fatty Liver , Sarcoma , Mice , Animals , Liver , Fluorouracil/pharmacology
2.
An. acad. bras. ciênc ; 89(2): 1073-1084, Apr.-June 2017. tab, graf
Article in English | LILACS | ID: biblio-886689

ABSTRACT

ABSTRACT This study aimed to evaluate the teratogenic and hepatotoxic potential of the usnic acid encapsulated into PLGA-microspheres. In total, 12 female Wistar rats in pregnancy were randomly distributed in the control group (n= 6) that received 1.0 mL of physiological solution and treatment group (n= 6) that received 25 mg/kg of encapsulated usnic acid by oral administration. All females were euthanized at day 20 of pregnancy and their fetuses were removed and analyzed. During the pregnancy was observed a reduction in weight gain. There was no difference in serum transaminases levels analyzed as well as any difference in liver weight in both groups. The histomorphometric analysis of the liver from the treatment group revealed an increase in number of hepatocytes and a decrease in nuclear area of these cells. Moreover, no alteration was observed in cell area of hepatocytes or number of Kupffer cells. The fetuses had an increase in total number of hepatocytes and a reduction in the amount of megakaryocytes. These results show the hepatotoxic potential of usnic acid during pregnancy. However, its toxicity can be minimized by encapsulation in microspheres.


Subject(s)
Animals , Female , Pregnancy , Polyglycolic Acid/toxicity , Ascomycota/chemistry , Benzofurans/toxicity , Lactic Acid/toxicity , Fetus/drug effects , Lichens/chemistry , Liver/drug effects , Polyglycolic Acid/chemistry , Reference Values , Abnormalities, Drug-Induced , Benzofurans/chemistry , Random Allocation , Rats, Wistar , Maternal Exposure , Lactic Acid/chemistry , Fetal Weight/drug effects , Hepatocytes/drug effects , Polylactic Acid-Polyglycolic Acid Copolymer , Liver/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...